In the News: Relation of Oral Bisphosphonates to Bone Marrow Lesion Volume among Women with Osteoarthritis
In the News – Tuhina Neogi publication – Bone drug may be beneficial in the treatment of OA
Ballal, P., et al. (2020) The Relation of Oral Bisphosphonates to Bone Marrow Lesion Volume among Women with Osteoarthritis. Osteoarthritis and Cartilage.
“When we looked at those who had bone marrow lesions at baseline, we found that the women who started bisphosphonates had had more bone marrow lesions that decreased in size than the women who did not start bisphosphonates. These results suggest that bisphosphonates do not appear to be harmful, at least over one year, and perhaps may even help decrease bone marrow lesions in those that have them.”
Tuhina Neogi, MD, PhD, corresponding author, Professor of Medicine and Epidemiology at Boston University Schools of Medicine and Public Health